Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.

Chevalley, Thierry; Brandi, Maria Luisa; Cashman, Kevin D; Cavalier, Etienne; Harvey, Nicholas C; Maggi, Stefania; Cooper, Cyrus; Al-Daghri, Nasser; Bock, Oliver; Bruyère, Olivier; Rosa, Mario Miguel; Cortet, Bernard; Cruz-Jentoft, Alfonso J; Cherubini, Antonio; Dawson-Hughes, Bess; Fielding, Roger; Fuggle, Nicholas; Halbout, Philippe; Kanis, John A; Kaufman, Jean-Marc; ... (2022). Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging clinical and experimental research, 34(11), pp. 2603-2623. Springer 10.1007/s40520-022-02279-6

Preview

Text s40520-022-02279-6.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview

Vitamin D is a key component for optimal growth and for calcium-phosphate homeostasis. Skin photosynthesis is the main source of vitamin D. Limited sun exposure and insufficient dietary vitamin D supply justify vitamin D supplementation in certain age groups. In older adults, recommended doses for vitamin D supplementation vary between 200 and 2000 IU/day, to achieve a goal of circulating 25-hydroxyvitamin D (calcifediol) of at least 50 nmol/L. The target level depends on the population being supplemented, the assessed system, and the outcome. Several recent large randomized trials with oral vitamin D regimens varying between 2000 and 100,000 IU/month and mostly conducted in vitamin D-replete and healthy individuals have failed to detect any efficacy of these approaches for the prevention of fracture and falls. Considering the well-recognized major musculoskeletal disorders associated with severe vitamin D deficiency and taking into account a possible biphasic effects of vitamin D on fracture and fall risks, an European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group convened, carefully reviewed, and analyzed the meta-analyses of randomized controlled trials on the effects of vitamin D on fracture risk, falls or osteoarthritis, and came to the conclusion that 1000 IU daily should be recommended in patients at increased risk of vitamin D deficiency. The group also addressed the identification of patients possibly benefitting from a vitamin D loading dose to achieve early 25-hydroxyvitamin D therapeutic level or from calcifediol administration.

Interest & Impact

Downloads

49 since deposited on 28 Oct 2022
19 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item